Seeking Alpha

Actelion (ALIOY.PK), Europe's biggest biotech company, posts encouraging results from a...

Actelion (ALIOY.PK), Europe's biggest biotech company, posts encouraging results from a mid-stage clinical trial of ponesimod, a treatment for skin disease psoriasis, with 46% of patients suffering from moderate to severe chronic plaque psoriasis seeing a 75% improvement in an index for monitoring the disease at 16 weeks when treated with a 20 milligram dose.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|